Khan B J, Kumar A M V, Stewart A, Khan N M, Selvaraj K, Fatima R, Samad Z
National Tuberculosis Control Program, Islamabad, Pakistan.
International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India.
Public Health Action. 2017 Jun 21;7(2):127-133. doi: 10.5588/pha.17.0001.
All public-private mix (PPM) facilities caring for tuberculosis (TB) patients in Lahore city, Pakistan, under four models: PPM1 (general practitioners), PPM2 (non-governmental organisations), PPM3 (private hospitals) and PPM4 (others). To assess the pre-treatment loss to follow-up (LTFU), defined as patients documented in the laboratory registers but not in the treatment registers of any PPM facility, among sputum smear-positive TB patients diagnosed during January-March 2015, and unfavourable treatment outcomes among patients registered for treatment and associated factors. This was a retrospective cohort study reviewing existing programme records. Poisson regression was used to identify factors associated with outcomes. Of 2473 patients diagnosed, 1590 (64%) were lost to follow-up before treatment. This was higher among males (68%) and the elderly (79%), and lower among 'high positives' (smear grading 2+ or 3+, 53%) and in the PPM1 model (34%). Of 883 patients started on treatment, 165 (19%) had unfavourable outcomes: 8% LTFU, 5% treatment failure, 3% died and 3% not evaluated. Previously treated patients (34%) and children (44%) had the worst outcomes. Pre-treatment LTFU was alarmingly high and requires urgent attention, including the development and institution of mechanisms for patient tracking using information and mobile phone technology, and making TB notification mandatory in the private sector.
在巴基斯坦拉合尔市,所有按照四种模式为结核病患者提供治疗的公私混合(PPM)机构:PPM1(全科医生)、PPM2(非政府组织)、PPM3(私立医院)和PPM4(其他)。评估2015年1月至3月期间诊断出的痰涂片阳性结核病患者治疗前失访情况(LTFU),即实验室登记在册但未在任何PPM机构治疗登记册中的患者,以及已登记接受治疗患者的不良治疗结局及其相关因素。这是一项回顾性队列研究,审查现有的项目记录。采用泊松回归分析确定与结局相关的因素。在2473名确诊患者中,1590名(64%)在治疗前失访。男性(68%)和老年人(79%)的失访率较高,“高阳性”患者(涂片分级2+或3+,53%)和PPM1模式下的患者(34%)失访率较低。在883名开始治疗的患者中,165名(19%)出现不良结局:8%失访、5%治疗失败、3%死亡和3%未评估。既往接受过治疗的患者(34%)和儿童(44%)结局最差。治疗前失访率高得惊人,需要紧急关注,包括利用信息和移动电话技术开发并建立患者追踪机制,以及强制私营部门通报结核病情况。